The Effects of Study Products Containing Varying Quantities of Docosahexaenoic Acid (DHA)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical trial will provide a milk-based drink with constant amounts of nutrients but differing amount of Docosahexaenoic Acid (DHA).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules

NCT05802797

Healthy Diet

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults

NCT02514070

Lipoprotein Metabolism PCSK9 Proteomics

COMPLETED PHASE2

Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance

NCT03259412

Exercise-induced Inflammation

COMPLETED NA

The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity

NCT01692431

Cardiovascular Physiological Phenomena Endothelial Nitric Oxide Synthase Eicosapentaenoic Acid +1 more

COMPLETED NA

Pharmacokinetics of Omega-3 Monoglycerides

NCT04382027

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Levels of DHA in the Blood

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Milk-based beverage w/out DHA

Group Type PLACEBO_COMPARATOR

Nutritional beverage

Intervention Type OTHER

Milk-based beverage with DHA

Group Type EXPERIMENTAL

Nutritional beverage

Intervention Type OTHER

Milk-based beverage containing DHA at a higher level

Group Type EXPERIMENTAL

Nutritional beverage

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutritional beverage

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is 18 to 36 months of age
* Participant's current weight and height within the 10th to 90th percentiles
* Parent/caregiver reports that participant consumes milk or a milk-based beverage on a daily basis
* Participant lives at home with parent(s) or other family member(s)
* Signed informed consent and authorization obtained to use and or disclose Protected Health Information (PHI)

Exclusion Criteria

* Participant who is receiving any breast milk at time of randomization
* Participant with an active infection.
* Participant with a history of underlying disease, chronic disease, or congenital malformation which in the opinion of the Investigator is likely to interfere with the evaluation of the participant.
* Known or suspected intolerance to cow's milk protein
* Participant diagnosed with diabetes
* Participant is from a multiple birth and the sibling(s) are still living
* Participant with a sibling that has participated in this study.

Minimum Eligible Age

18 Months

Maximum Eligible Age

36 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes